Fr171 LOSS OF HISTOLOGIC, SYMPTOM AND ENDOSCOPIC EFFICACY FOLLOWING TREATMENT WITHDRAWAL IN PATIENTS WITH EOSINOPHILIC ESOPHAGITIS: A PHASE 3, RANDOMIZED WITHDRAWAL STUDY OF BUDESONIDE ORAL SUSPENSION